Development of a cytology-based multivariate analytical risk index for oral cancer

•An accurate Multivariate Analytical Risk Index for Oral Cancer has been developed.•Accuracy ranged from 76.0–82.4–89.6% for benign, dysplastic, malignant lesions.•MARIO represents a new noninvasive tool to assist in disease monitoring of PMOL. The diagnosis and management of oral cavity cancers are...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oral oncology 2019-05, Vol.92, p.6-11
Hauptverfasser: Abram, Timothy J., Floriano, Pierre N., James, Robert, Kerr, A. Ross, Thornhill, Martin H., Redding, Spencer W., Vigneswaran, Nadarajah, Raja, Rameez, McRae, Michael P., McDevitt, John T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11
container_issue
container_start_page 6
container_title Oral oncology
container_volume 92
creator Abram, Timothy J.
Floriano, Pierre N.
James, Robert
Kerr, A. Ross
Thornhill, Martin H.
Redding, Spencer W.
Vigneswaran, Nadarajah
Raja, Rameez
McRae, Michael P.
McDevitt, John T.
description •An accurate Multivariate Analytical Risk Index for Oral Cancer has been developed.•Accuracy ranged from 76.0–82.4–89.6% for benign, dysplastic, malignant lesions.•MARIO represents a new noninvasive tool to assist in disease monitoring of PMOL. The diagnosis and management of oral cavity cancers are often complicated by the uncertainty of which patients will undergo malignant transformation, obligating close surveillance over time. However, serial biopsies are undesirable, highly invasive, and subject to inherent issues with poor inter-pathologist agreement and unpredictability as a surrogate for malignant transformation and clinical outcomes. The goal of this study was to develop and evaluate a Multivariate Analytical Risk Index for Oral Cancer (MARIO) with potential to provide non-invasive, sensitive, and quantitative risk assessments for monitoring lesion progression. A series of predictive models were developed and validated using previously recorded single-cell data from oral cytology samples resulting in a “continuous risk score”. Model development consisted of: (1) training base classification models for each diagnostic class pair, (2) pairwise coupling to obtain diagnostic class probabilities, and (3) a weighted aggregation resulting in a continuous MARIO. Diagnostic accuracy based on optimized cut-points for the test dataset ranged from 76.0% for Benign, to 82.4% for Dysplastic, 89.6% for Malignant, and 97.6% for Normal controls for an overall MARIO accuracy of 72.8%. Furthermore, a strong positive relationship with diagnostic severity was demonstrated (Pearson’s coefficient = 0.805 for test dataset) as well as the ability of the MARIO to respond to subtle changes in cell composition. The development of a continuous MARIO for PMOL is presented, resulting in a sensitive, accurate, and non-invasive method with potential for enabling monitoring disease progression, recurrence, and the need for therapeutic intervention of these lesions.
doi_str_mv 10.1016/j.oraloncology.2019.02.011
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7358989</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1368837519300478</els_id><sourcerecordid>2213159328</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-75202922ec02cbb5529ee3dff2214725860eb31dc7982b93853d2889028af90f3</originalsourceid><addsrcrecordid>eNqNkVFPHCEUhUlTU63tX2iIT32Z8QIyA31o0mirJiYmRp8Jw9yxbJlhhdlN99_Ldq3RN58g4dxzD-cj5IhBzYA1x4s6Jhvi5GKI95uaA9M18BoYe0cOmGp1BVKL9-UuGlUp0cp98jHnBQBIJuED2RfFBxreHJCbM1xjiMsRp5nGgVrqNvM_36qzGXs6rsLs1zZ5OyO1kw2b2TsbaPL5D_VTj3_pEBPdJqLOTg7TJ7I32JDx89N5SO5-_bw9vaiurs8vT39cVe5EtXPVSg5cc44OuOs6KblGFP0wcM5OWi5VA9gJ1rtWK95poaTouVIauLKDhkEcku873-WqG7F35QclhFkmP9q0MdF68_pl8r_NfVybVkillS4GX58MUnxYYZ7N6LPDEOyEcZVNCSJYaZKrIv22k7oUc044PK9hYLZQzMK8hGK2UAxwU6CU4S8vgz6P_qdQBGc7AZa61h6Tyc5j6bL3Cd1s-ujfsucREsOmgQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2213159328</pqid></control><display><type>article</type><title>Development of a cytology-based multivariate analytical risk index for oral cancer</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Abram, Timothy J. ; Floriano, Pierre N. ; James, Robert ; Kerr, A. Ross ; Thornhill, Martin H. ; Redding, Spencer W. ; Vigneswaran, Nadarajah ; Raja, Rameez ; McRae, Michael P. ; McDevitt, John T.</creator><creatorcontrib>Abram, Timothy J. ; Floriano, Pierre N. ; James, Robert ; Kerr, A. Ross ; Thornhill, Martin H. ; Redding, Spencer W. ; Vigneswaran, Nadarajah ; Raja, Rameez ; McRae, Michael P. ; McDevitt, John T.</creatorcontrib><description>•An accurate Multivariate Analytical Risk Index for Oral Cancer has been developed.•Accuracy ranged from 76.0–82.4–89.6% for benign, dysplastic, malignant lesions.•MARIO represents a new noninvasive tool to assist in disease monitoring of PMOL. The diagnosis and management of oral cavity cancers are often complicated by the uncertainty of which patients will undergo malignant transformation, obligating close surveillance over time. However, serial biopsies are undesirable, highly invasive, and subject to inherent issues with poor inter-pathologist agreement and unpredictability as a surrogate for malignant transformation and clinical outcomes. The goal of this study was to develop and evaluate a Multivariate Analytical Risk Index for Oral Cancer (MARIO) with potential to provide non-invasive, sensitive, and quantitative risk assessments for monitoring lesion progression. A series of predictive models were developed and validated using previously recorded single-cell data from oral cytology samples resulting in a “continuous risk score”. Model development consisted of: (1) training base classification models for each diagnostic class pair, (2) pairwise coupling to obtain diagnostic class probabilities, and (3) a weighted aggregation resulting in a continuous MARIO. Diagnostic accuracy based on optimized cut-points for the test dataset ranged from 76.0% for Benign, to 82.4% for Dysplastic, 89.6% for Malignant, and 97.6% for Normal controls for an overall MARIO accuracy of 72.8%. Furthermore, a strong positive relationship with diagnostic severity was demonstrated (Pearson’s coefficient = 0.805 for test dataset) as well as the ability of the MARIO to respond to subtle changes in cell composition. The development of a continuous MARIO for PMOL is presented, resulting in a sensitive, accurate, and non-invasive method with potential for enabling monitoring disease progression, recurrence, and the need for therapeutic intervention of these lesions.</description><identifier>ISSN: 1368-8375</identifier><identifier>EISSN: 1879-0593</identifier><identifier>DOI: 10.1016/j.oraloncology.2019.02.011</identifier><identifier>PMID: 31010626</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Biopsy ; Cytodiagnosis - instrumentation ; Cytodiagnosis - methods ; Cytodiagnosis - standards ; Cytology ; Humans ; Lab-On-A-Chip Devices ; Model ensembles ; Mouth Neoplasms - diagnosis ; Multi-class classification ; Multivariate Analysis ; Neoplasm Grading ; Neoplasm Staging ; Oral cancer ; Reproducibility of Results ; Risk Assessment</subject><ispartof>Oral oncology, 2019-05, Vol.92, p.6-11</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-75202922ec02cbb5529ee3dff2214725860eb31dc7982b93853d2889028af90f3</citedby><cites>FETCH-LOGICAL-c487t-75202922ec02cbb5529ee3dff2214725860eb31dc7982b93853d2889028af90f3</cites><orcidid>0000-0003-0681-4083</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.oraloncology.2019.02.011$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,315,781,785,886,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31010626$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abram, Timothy J.</creatorcontrib><creatorcontrib>Floriano, Pierre N.</creatorcontrib><creatorcontrib>James, Robert</creatorcontrib><creatorcontrib>Kerr, A. Ross</creatorcontrib><creatorcontrib>Thornhill, Martin H.</creatorcontrib><creatorcontrib>Redding, Spencer W.</creatorcontrib><creatorcontrib>Vigneswaran, Nadarajah</creatorcontrib><creatorcontrib>Raja, Rameez</creatorcontrib><creatorcontrib>McRae, Michael P.</creatorcontrib><creatorcontrib>McDevitt, John T.</creatorcontrib><title>Development of a cytology-based multivariate analytical risk index for oral cancer</title><title>Oral oncology</title><addtitle>Oral Oncol</addtitle><description>•An accurate Multivariate Analytical Risk Index for Oral Cancer has been developed.•Accuracy ranged from 76.0–82.4–89.6% for benign, dysplastic, malignant lesions.•MARIO represents a new noninvasive tool to assist in disease monitoring of PMOL. The diagnosis and management of oral cavity cancers are often complicated by the uncertainty of which patients will undergo malignant transformation, obligating close surveillance over time. However, serial biopsies are undesirable, highly invasive, and subject to inherent issues with poor inter-pathologist agreement and unpredictability as a surrogate for malignant transformation and clinical outcomes. The goal of this study was to develop and evaluate a Multivariate Analytical Risk Index for Oral Cancer (MARIO) with potential to provide non-invasive, sensitive, and quantitative risk assessments for monitoring lesion progression. A series of predictive models were developed and validated using previously recorded single-cell data from oral cytology samples resulting in a “continuous risk score”. Model development consisted of: (1) training base classification models for each diagnostic class pair, (2) pairwise coupling to obtain diagnostic class probabilities, and (3) a weighted aggregation resulting in a continuous MARIO. Diagnostic accuracy based on optimized cut-points for the test dataset ranged from 76.0% for Benign, to 82.4% for Dysplastic, 89.6% for Malignant, and 97.6% for Normal controls for an overall MARIO accuracy of 72.8%. Furthermore, a strong positive relationship with diagnostic severity was demonstrated (Pearson’s coefficient = 0.805 for test dataset) as well as the ability of the MARIO to respond to subtle changes in cell composition. The development of a continuous MARIO for PMOL is presented, resulting in a sensitive, accurate, and non-invasive method with potential for enabling monitoring disease progression, recurrence, and the need for therapeutic intervention of these lesions.</description><subject>Biopsy</subject><subject>Cytodiagnosis - instrumentation</subject><subject>Cytodiagnosis - methods</subject><subject>Cytodiagnosis - standards</subject><subject>Cytology</subject><subject>Humans</subject><subject>Lab-On-A-Chip Devices</subject><subject>Model ensembles</subject><subject>Mouth Neoplasms - diagnosis</subject><subject>Multi-class classification</subject><subject>Multivariate Analysis</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Staging</subject><subject>Oral cancer</subject><subject>Reproducibility of Results</subject><subject>Risk Assessment</subject><issn>1368-8375</issn><issn>1879-0593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkVFPHCEUhUlTU63tX2iIT32Z8QIyA31o0mirJiYmRp8Jw9yxbJlhhdlN99_Ldq3RN58g4dxzD-cj5IhBzYA1x4s6Jhvi5GKI95uaA9M18BoYe0cOmGp1BVKL9-UuGlUp0cp98jHnBQBIJuED2RfFBxreHJCbM1xjiMsRp5nGgVrqNvM_36qzGXs6rsLs1zZ5OyO1kw2b2TsbaPL5D_VTj3_pEBPdJqLOTg7TJ7I32JDx89N5SO5-_bw9vaiurs8vT39cVe5EtXPVSg5cc44OuOs6KblGFP0wcM5OWi5VA9gJ1rtWK95poaTouVIauLKDhkEcku873-WqG7F35QclhFkmP9q0MdF68_pl8r_NfVybVkillS4GX58MUnxYYZ7N6LPDEOyEcZVNCSJYaZKrIv22k7oUc044PK9hYLZQzMK8hGK2UAxwU6CU4S8vgz6P_qdQBGc7AZa61h6Tyc5j6bL3Cd1s-ujfsucREsOmgQ</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Abram, Timothy J.</creator><creator>Floriano, Pierre N.</creator><creator>James, Robert</creator><creator>Kerr, A. Ross</creator><creator>Thornhill, Martin H.</creator><creator>Redding, Spencer W.</creator><creator>Vigneswaran, Nadarajah</creator><creator>Raja, Rameez</creator><creator>McRae, Michael P.</creator><creator>McDevitt, John T.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0681-4083</orcidid></search><sort><creationdate>20190501</creationdate><title>Development of a cytology-based multivariate analytical risk index for oral cancer</title><author>Abram, Timothy J. ; Floriano, Pierre N. ; James, Robert ; Kerr, A. Ross ; Thornhill, Martin H. ; Redding, Spencer W. ; Vigneswaran, Nadarajah ; Raja, Rameez ; McRae, Michael P. ; McDevitt, John T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-75202922ec02cbb5529ee3dff2214725860eb31dc7982b93853d2889028af90f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Biopsy</topic><topic>Cytodiagnosis - instrumentation</topic><topic>Cytodiagnosis - methods</topic><topic>Cytodiagnosis - standards</topic><topic>Cytology</topic><topic>Humans</topic><topic>Lab-On-A-Chip Devices</topic><topic>Model ensembles</topic><topic>Mouth Neoplasms - diagnosis</topic><topic>Multi-class classification</topic><topic>Multivariate Analysis</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Staging</topic><topic>Oral cancer</topic><topic>Reproducibility of Results</topic><topic>Risk Assessment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abram, Timothy J.</creatorcontrib><creatorcontrib>Floriano, Pierre N.</creatorcontrib><creatorcontrib>James, Robert</creatorcontrib><creatorcontrib>Kerr, A. Ross</creatorcontrib><creatorcontrib>Thornhill, Martin H.</creatorcontrib><creatorcontrib>Redding, Spencer W.</creatorcontrib><creatorcontrib>Vigneswaran, Nadarajah</creatorcontrib><creatorcontrib>Raja, Rameez</creatorcontrib><creatorcontrib>McRae, Michael P.</creatorcontrib><creatorcontrib>McDevitt, John T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oral oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abram, Timothy J.</au><au>Floriano, Pierre N.</au><au>James, Robert</au><au>Kerr, A. Ross</au><au>Thornhill, Martin H.</au><au>Redding, Spencer W.</au><au>Vigneswaran, Nadarajah</au><au>Raja, Rameez</au><au>McRae, Michael P.</au><au>McDevitt, John T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of a cytology-based multivariate analytical risk index for oral cancer</atitle><jtitle>Oral oncology</jtitle><addtitle>Oral Oncol</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>92</volume><spage>6</spage><epage>11</epage><pages>6-11</pages><issn>1368-8375</issn><eissn>1879-0593</eissn><abstract>•An accurate Multivariate Analytical Risk Index for Oral Cancer has been developed.•Accuracy ranged from 76.0–82.4–89.6% for benign, dysplastic, malignant lesions.•MARIO represents a new noninvasive tool to assist in disease monitoring of PMOL. The diagnosis and management of oral cavity cancers are often complicated by the uncertainty of which patients will undergo malignant transformation, obligating close surveillance over time. However, serial biopsies are undesirable, highly invasive, and subject to inherent issues with poor inter-pathologist agreement and unpredictability as a surrogate for malignant transformation and clinical outcomes. The goal of this study was to develop and evaluate a Multivariate Analytical Risk Index for Oral Cancer (MARIO) with potential to provide non-invasive, sensitive, and quantitative risk assessments for monitoring lesion progression. A series of predictive models were developed and validated using previously recorded single-cell data from oral cytology samples resulting in a “continuous risk score”. Model development consisted of: (1) training base classification models for each diagnostic class pair, (2) pairwise coupling to obtain diagnostic class probabilities, and (3) a weighted aggregation resulting in a continuous MARIO. Diagnostic accuracy based on optimized cut-points for the test dataset ranged from 76.0% for Benign, to 82.4% for Dysplastic, 89.6% for Malignant, and 97.6% for Normal controls for an overall MARIO accuracy of 72.8%. Furthermore, a strong positive relationship with diagnostic severity was demonstrated (Pearson’s coefficient = 0.805 for test dataset) as well as the ability of the MARIO to respond to subtle changes in cell composition. The development of a continuous MARIO for PMOL is presented, resulting in a sensitive, accurate, and non-invasive method with potential for enabling monitoring disease progression, recurrence, and the need for therapeutic intervention of these lesions.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31010626</pmid><doi>10.1016/j.oraloncology.2019.02.011</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-0681-4083</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1368-8375
ispartof Oral oncology, 2019-05, Vol.92, p.6-11
issn 1368-8375
1879-0593
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7358989
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Biopsy
Cytodiagnosis - instrumentation
Cytodiagnosis - methods
Cytodiagnosis - standards
Cytology
Humans
Lab-On-A-Chip Devices
Model ensembles
Mouth Neoplasms - diagnosis
Multi-class classification
Multivariate Analysis
Neoplasm Grading
Neoplasm Staging
Oral cancer
Reproducibility of Results
Risk Assessment
title Development of a cytology-based multivariate analytical risk index for oral cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T10%3A18%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20a%20cytology-based%20multivariate%20analytical%20risk%20index%20for%20oral%20cancer&rft.jtitle=Oral%20oncology&rft.au=Abram,%20Timothy%20J.&rft.date=2019-05-01&rft.volume=92&rft.spage=6&rft.epage=11&rft.pages=6-11&rft.issn=1368-8375&rft.eissn=1879-0593&rft_id=info:doi/10.1016/j.oraloncology.2019.02.011&rft_dat=%3Cproquest_pubme%3E2213159328%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2213159328&rft_id=info:pmid/31010626&rft_els_id=S1368837519300478&rfr_iscdi=true